Art

J-GLOBAL ID：201102218770597540   Reference number：11A1033142

Present Status of Anticoagulation Treatment in Japanese Patients With Atrial Fibrillation - A Report From the J-RHYTHM Registry -

日本の心房細動患者における抗凝固療法の現状-J-RHYTHMによる報告

Author (7)： ATARASHI Hirotsugu (Dep. of Internal Medicine, Nippon Medical School Tama-Nagayama Hospital) ,  INOUE Hiroshi (The Second Dep. of Internal Medicine, Univ. of Toyama, Graduate School of Medicine) ,  OKUMURA Ken (Cardiology, Respiratory Medicine and Nephrology, Hirosaki Univ. Graduate School of Medicine) ,  YAMASHITA Takeshi (The Cardiovascular Inst.) ,  KUMAGAI Naoko (Kochi Medical School Clinical Res. Center, Kochi Univ.) ,  ORIGASA Hideki (Div. of Biostatistics and Clinical Epidemiology, Univ. of Toyama, Graduate School of Medicine) ,  THE J-RHYTHM REGISTRY I
Material： Circulation Journal  (Circ J)
Volume： 75  Issue： 6  Page： 1328-1333 (J-STAGE)  Publication year： 2011 
JST Material Number： F0908A  ISSN： 1346-9843  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： Japan ,...
Semi thesaurus term： Japanese rhythm management trial ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=11A1033142&from=J-GLOBAL&jstjournalNo=F0908A") }}

JST classification (2)： Clinical application of drugs acting on blood and body fluid  (GW14020X) ,  Drug therapy(=pharmacotherapy)for cardiovascular system diseases  (GJ05020M)

Substance index (2)： Warfarin ,  Aspirin

Reference (24)：

• 1. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and Heart Rhythm Society. Circulation 2006; 114: 700-752.
• 2. Ogawa S, Aizawa Y, Atarashi H, Inoue H, Okumura K, Kamakura S. Guidelines for pharmacotherapy of atrial fibrillation. Circ J 2008; 72(Suppl IV): 1639-1658 (in Japanese).
• 3. Yasaka M, Minematsu K, Yamaguchi T. Optimal intensity of international normalized ratio in warfarin therapy for secondary prevention of stroke in patients with non-valvular atrial fibrillation. Intern Med 2001; 40: 1183-1188.
• 4. Shen AYJ, Yao JF, Brar SS, Jorgensen MB, Chen W. Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation. J Am Coll Cardiol 2007; 50: 309-315.
• 5. Johnson JA. Ethnic differences in cardiovascular drug response: Potential contribution of pharmacogenetics. Circulation 2008; 118: 1383-1393.

Terms in the title (6)： 日本 ,  心房細動 ,  患者 ,  抗凝固療法 ,  現状 ,  報告